No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | ACHC | Acadia Healthcare | Rating: Hold | $72 | 06-17-2022 | View Chart |
2 | ANTM | Anthem | Rating: Buy | $550 | 06-17-2022 | View Chart |
3 | APG | APi Group | Rating: Neutral | $17 | 06-17-2022 | View Chart |
4 | BEAM | Beam Therapeutics | Rating: Market Perform | $41 | 06-17-2022 | View Chart |
5 | BEEM | Beam Global | Rating: Buy | $23 | 06-17-2022 | View Chart |
6 | BLNK | Blink Charging | Rating: Neutral | $15 | 06-17-2022 | View Chart |
7 | BRMK | Broadmark Realty | Rating: Neutral | $7 | 06-17-2022 | View Chart |
8 | CHPT | ChargePoint | Rating: Buy | $20 | 06-17-2022 | View Chart |
9 | CI | Cigna | Rating: Hold | $270 | 06-17-2022 | View Chart |
10 | CNC | Centene | Rating: Buy | $100 | 06-17-2022 | View Chart |
11 | CNTA | Centessa Pharmaceuticals | Rating: Outperform | $19 | 06-17-2022 | View Chart |
12 | CRSP | CRISPR Therapeutics | Rating: Outperform | $98 | 06-17-2022 | View Chart |
13 | CTO | CTO Realty Growth | Rating: Outperform | $69 | 06-17-2022 | View Chart |
14 | CVS | CVS Health | Rating: Buy | $120 | 06-17-2022 | View Chart |
15 | CVT | Cvent | Rating: Equal-Weight | $5.50 | 06-17-2022 | View Chart |
16 | CYH | Community Health | Rating: Hold | $5 | 06-17-2022 | View Chart |
17 | DCFC | Tritium DCFC | Rating: Buy | $12 | 06-17-2022 | View Chart |
18 | DTIL | Precision BioSciences | Rating: Outperform | $7 | 06-17-2022 | View Chart |
19 | GRAB | Grab | Rating: Buy | $3.20 | 06-17-2022 | View Chart |
20 | GRPH | Graphite Bio | Rating: Outperform | $12 | 06-17-2022 | View Chart |
21 | HCA | HCA | Rating: Buy | $240 | 06-17-2022 | View Chart |
22 | HUBG | Hub Group | Rating: Buy | $90 | 06-17-2022 | View Chart |
23 | HUM | Humana | Rating: Buy | $510 | 06-17-2022 | View Chart |
24 | LEGN | Legend Biotech | Rating: Outperform | $77 | 06-17-2022 | View Chart |
25 | LFG | Archaea Energy | Rating: Overweight | $26 | 06-17-2022 | View Chart |
26 | MOH | Molina Healthcare | Rating: Hold | $310 | 06-17-2022 | View Chart |
27 | NTLA | Intellia Therapeutics | Rating: Market Perform | $54 | 06-17-2022 | View Chart |
28 | PRPB | CC Neuberger Principal Holdings II | Rating: Buy | $12 | 06-17-2022 | View Chart |
29 | STRY | Starry | Rating: Outperform | $9 | 06-17-2022 | View Chart |
30 | THC | Tenet Healthcare | Rating: Buy | $80 | 06-17-2022 | View Chart |
31 | UHS | Universal Health | Rating: Hold | $115 | 06-17-2022 | View Chart |
32 | UNH | UnitedHealth | Rating: Buy | $575 | 06-17-2022 | View Chart |
33 | VERV | Verve Therapeutics | Rating: Outperform | $48 | 06-17-2022 | View Chart |
34 | ZIMV | ZimVie | Rating: Neutral | $20 | 06-17-2022 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | APLS | Apellis Pharmaceuticals | Rating: Buy | $60 | 06-17-2022 | View Chart |
2 | CRH | CRH Plc. | Rating: Buy | $-- | 06-17-2022 | View Chart |
3 | QDEL | QuidelOrtho | Rating: Neutral | $80>>110 | 06-17-2022 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | RYTM | Rhythm Pharmaceuticals | Rating: Buy | $40>>25 | 06-17-2022 | View Chart |
2 | USER | UserTesting | Rating: Outperform | $14>>12 | 06-17-2022 | View Chart |
3 | X | U.S. Steel | Rating: Outperform | $49>>44 | 06-17-2022 | View Chart |